Nippon Life Global Investors Americas’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-880
| Closed | -$925K | – | 112 |
|
|
2024
Q3 | $925K | Buy |
880
+40
| +5% | +$44.5K | 0.04% | 95 |
|
|
2024
Q2 | $883K | Sell |
840
-230
| -21% | -$223K | 0.04% | 89 |
|
|
2024
Q1 | $1.03M | Sell |
1,070
-60
| -5% | -$57.1K | 0.05% | 87 |
|
|
2023
Q4 | $992K | Sell |
1,130
-360
| -24% | -$296K | 0.06% | 110 |
|
|
2023
Q3 | $1.23M | Hold |
1,490
| – | – | 0.08% | 104 |
|
|
2023
Q2 | $1.07M | Hold |
1,490
| – | – | 0.07% | 109 |
|
|
2023
Q1 | $1.22M | Sell |
1,490
-430
| -22% | -$324K | 0.08% | 105 |
|
|
2022
Q4 | $1.39M | Sell |
1,920
-29,000
| -94% | -$21.4M | 0.09% | 102 |
|
|
2022
Q3 | $21.3M | Buy |
30,920
+1,320
| +4% | +$831K | 1.5% | 20 |
|
|
2022
Q2 | $17.5M | Sell |
29,600
-1,710
| -5% | -$1.11M | 1.13% | 27 |
|
|
2022
Q1 | $21.9M | Sell |
31,310
-12,720
| -29% | -$8.05M | 1.17% | 22 |
|
|
2021
Q4 | $27.8M | Buy |
44,030
+3,160
| +8% | +$1.94M | 1.31% | 15 |
|
|
2021
Q3 | $24.7M | Buy |
40,870
+32,450
| +385% | +$20.1M | 1.29% | 16 |
|
|
2021
Q2 | $4.7M | Hold |
8,420
| – | – | 0.23% | 105 |
|
|
2021
Q1 | $3.98M | Hold |
8,420
| – | – | 0.22% | 107 |
|
|
2020
Q4 | $4.07M | Hold |
8,420
| – | – | 0.24% | 94 |
|
|
2020
Q3 | $4.71M | Hold |
8,420
| – | – | 0.31% | 80 |
|
|
2020
Q2 | $5.25M | Sell |
8,420
-130
| -2% | -$73.8K | 0.38% | 68 |
|
|
2020
Q1 | $4.18M | Sell |
8,550
-44,420
| -84% | -$18.3M | 0.37% | 71 |
|
|
2019
Q4 | $19.9M | Buy |
52,970
+4,850
| +10% | +$1.63M | 1.35% | 18 |
|
|
2019
Q3 | $13.3M | Buy |
48,120
+18,320
| +61% | +$5.42M | 0.98% | 32 |
|
|
2019
Q2 | $9.33M | Buy |
29,800
+22,940
| +334% | +$7.64M | 0.71% | 50 |
|
|
2019
Q1 | $2.82M | Sell |
6,860
-32,220
| -82% | -$13.3M | 0.23% | 107 |
|
|
2018
Q4 | $14.6M | Sell |
39,080
-60
| -0.2% | -$22K | 1.26% | 25 |
|
|
2018
Q3 | $15.8M | Buy |
39,140
+5,220
| +15% | +$1.99M | 1.21% | 27 |
|
|
2018
Q2 | $11.7M | Sell |
33,920
-4,130
| -11% | -$1.29M | 0.93% | 36 |
|
|
2018
Q1 | $13.1M | Buy |
38,050
+1,510
| +4% | +$525K | 1.08% | 28 |
|
|
2017
Q4 | $13.7M | Buy |
36,540
+7,610
| +26% | +$3.08M | 1.1% | 30 |
|
|
2017
Q3 | $12.9M | Sell |
28,930
-4,550
| -14% | -$2.17M | 1.1% | 32 |
|
|
2017
Q2 | $16.4M | Buy |
33,480
+27,790
| +488% | +$12.2M | 1.41% | 17 |
|
|
2017
Q1 | $2.21M | Buy |
+5,690
| New | +$2.11M | 0.2% | 113 |
|
|
2014
Q1 | – | Sell |
-5,430
| Closed | -$1.5M | – | 167 |
|
|
2013
Q4 | $1.5M | Buy |
+5,430
| New | +$1.56M | 0.15% | 130 |
|
Other funds holding REGN
Nippon Life Global Investors Americas's REGN Position: Q4 2024 in Review
Nippon Life Global Investors Americas sold out of Regeneron Pharmaceuticals (REGN) in Q4 2024, closing a stake of 880 shares — an estimated $925K sold.
Nippon Life Global Investors Americas first reported a position in REGN in Q4 2013 and held it in 32 quarters. The position peaked at $27.8M in Q4 2021. 1,318 funds tracked by Wall St. Rank hold REGN as of Q4 2024.
- Nippon Life Global Investors Americas reported no remaining Regeneron Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
- Nippon Life Global Investors Americas sold 880 Regeneron Pharmaceuticals shares in Q4 2024, an estimated $925K.
- Nippon Life Global Investors Americas first reported a position in Regeneron Pharmaceuticals in Q4 2013 and held it in 32 quarters.
- Nippon Life Global Investors Americas's Regeneron Pharmaceuticals position peaked at $27.8M in Q4 2021.
- 1,318 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.
Based on Nippon Life Global Investors Americas's 13F filing for Q4 2024, filed 14 Feb 2025.